Assignee
CYCLERION THERAPEUTICS INC
US·24 granted patents·24 pending applications·35 citations·filing 2015–2025
Top patents by PatentIndex Score
48 records- 0194US11708361B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Granted Jul 25, 2023·2 cites·14 claims
- 0293US12030874B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Granted Jul 9, 2024·1 cites·20 claims
- 0391US10858363B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Dec 8, 2020·4 cites·10 claims
- 0490US10639308B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2018·Granted May 5, 2020·3 cites·31 claims
- 0589US2025243228A1PHOSPHORUS PRODRUGS OF PYRAZOLO-SUBSTITUTED PYRIMIDINE sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0687US12275724B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·4 claims
- 0787US11274096B2Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Mar 15, 2022·2 cites·22 claims
- 0887US10889577B2Solid forms of an sGC stimulatorCYCLERION THERAPEUTICS INC·Filed 2017·Granted Jan 12, 2021·3 cites·24 claims
- 0987US10517874B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Dec 31, 2019·4 cites·17 claims
- 1086US11466015B2Crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl)imidazo[1,2-a]pyrazine as sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·3 cites·13 claims
- 1186US2024360164A1Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1286US2025243177A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1385US10472363B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Nov 12, 2019·3 cites·2 claims
- 1485US2024228520A9Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1583US2025129060A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1682US12247025B2Processes for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·0 cites·3 claims
- 1782US2024059683A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1882US2024293324A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1981US11834444B2Processes for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Dec 5, 2023·2 cites·18 claims
- 2081US2025017862A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2180US2024246947A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2279US2025361228A1Processes and intermediates for the preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2377US11690828B2Treatment of CNS diseases with sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Jul 4, 2023·2 cites·2 claims
- 2477US11466014B2Process for preparing soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·1 cites·11 claims
- 2577US11180493B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Nov 23, 2021·2 cites·10 claims
- 2677US10844064B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2015·Granted Nov 24, 2020·2 cites·9 claims
- 2777US2024059684A1Novel process for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2877US2023106002A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2976US11319308B2Processes for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·7 claims
- 3075US11731977B2SGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·0 cites·18 claims
- 3175US2025282769A1Solid forms of an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3273US11773089B2Process for preparation of soluble guanylate cyclase stimulatorsCYCLERION THERAPEUTICS INC·Filed 2022·Granted Oct 3, 2023·0 cites·13 claims
- 3373US11572358B2Solid forms of an sGC stimulatorCYCLERION THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·11 claims
- 3471US11207323B2sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·0 cites·4 claims
- 3571US2021087198A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3670US2021221793A1Pyrazole derivatives as sgc stimulatorsCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3770US2025255821A1Solid dispersions comprising a sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3867US10927136B2Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulatorsCYCLERION THERAPEUTICS INC·Filed 2017·Granted Feb 23, 2021·0 cites·16 claims
- 3961US2021214364A1sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4059US2024366596A1Treatment of hfpef in post-menopausal women with an sgc stimulatorCYCLERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4151US2021017160A1DEUTERATED sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4251US2021017161A1DEUTERATED sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4348US11389449B2Treatment of metabolic syndrome with an sGC stimulatorCYCLERION THERAPEUTICS INC·Filed 2018·Granted Jul 19, 2022·0 cites·21 claims
- 4448US2024165114A1TREATMENT OF DIABETIC NEPHROPATHY WITH AN sGC STIMULATORCYCLERION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4548US2019381039A1USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERSCYCLERION THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4647US11357777B2Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)CYCLERION THERAPEUTICS INC·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 4747US2023130739A1DEUTERATED sGC STIMULATORSCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4838US2023372335A1TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATORCYCLERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →